C-Reactive Protein-to-Albumin Ratio (CAR) as a Prognostic Biomarker in Newly Diagnosed Acute Myeloid Leukemia Treated with Intensive Induction Therapy: A Single-Center Retrospective Cohort Study
Objective: Inflammation plays an important role in acute myeloid leukemia (AML) biology and may influence clinical outcomes. The C-reactive protein-to-albumin ratio (CAR) is a simple marker of systemic inflammation. We evaluated the prognostic value of baseline CAR in patients with AML treated with intensive therapy.Ma...